Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

Video Credit: Wochit
Published on August 14, 2020 - Duration: 00:23s

Novavax Jumps 13% After UK Deal For 60 Million Doses Of COVID Vaccine

On Friday, shares of Novavax leaped as much as 13.3%.

It comes after Novavax finalized a deal with the UK to supply 60 million doses of its potential coronavirus vaccine.

The biotech company didn't reveal how much the UK paid for the doses.

According to a press release the UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine.


You are here

Related videos from verified sources

Moderna Cuts Deal With Japan for 40M Doses of Covid-19 Vaccine 02:33
Video credit: The Street - Published on August 28, 2020 

US government wants to distribute coronavirus vaccines for free 00:44
Video credit: nypost - Published on August 14, 2020 

Novavax and J&J Are Getting The Royal Treatment 02:57
Video credit: The Street - Published on August 14, 2020 

You might like